bioMérieux, an in vitro diagnostics company based in Paris, France, will unveil a new suite of “Full Microbiology Laboratory Automation” solutions at the 108th General Meeting of the American Society for Microbiology (ASM), held June 1-5 in Boston.
The products aim to streamline operations and make more reliable results available faster, particularly in light of the growing threat of healthcare-acquired infections, said the company.
“bioMérieux is leveraging its expertise in infectious diseases and the integration of innovative technologies to ‘deliver the future’ to the microbiology laboratory,” said Stéphane Bancel, Chief Executive Officer, bioMérieux.
“Driving full microbiology lab automation is bioMérieux’s number one priority, recognising the promise it brings to this industry as the role of the microbiologist becomes increasingly important – for patient care and food safety. bioMérieux is proud to be at the forefront of this movement.”
bioMérieux will premier three new microbiology laboratory automation platforms at ASM. bioMerieux’s PREVI Isola™, a pre-poured media streaker designed to automate routine agar plate processing; the PREVI™ Color Gram, bringing automation to a new lab procedure with its unique staining technology; and the UF-1000i, a urinary screening tool that allows laboratory technicians to accurately detect and enumerate the bacteria and particles present in urine specimens.
These systems are designed to complement bioMérieux’s complete range of automated solutions, including, BacT/ALERT® for blood culture, VITEK® 2 for identification and antibiotic susceptibility testing and DiversiLab™ for microbial straintyping.
